These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7900095)

  • 21. The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: influence of dosage regimens in rabbits.
    Agnelli G; Buchanan MR; Fernandez F; Hirsh J
    Thromb Res; 1985 Dec; 40(6):769-77. PubMed ID: 3937287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does external ultrasound accelerate thrombolysis? Results from a rabbit model.
    Kornowski R; Meltzer RS; Chernine A; Vered Z; Battler A
    Circulation; 1994 Jan; 89(1):339-44. PubMed ID: 8281667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of microvascular thrombosis with low-dose tissue plasminogen activator.
    Arnljots B; Wieslander JB; Dougan P; Salemark L
    Plast Reconstr Surg; 1992 Aug; 90(2):281-8. PubMed ID: 1631220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.
    Agnelli G; Buchanan MR; Fernandez F; Boneu B; Van Ryn J; Hirsh J; Collen D
    Circulation; 1985 Jul; 72(1):178-82. PubMed ID: 4039986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The thrombolytic activity of streptokinase in the rabbit.
    English PD; Smith RA; Dupe RJ; Green J; Hibbs MJ
    Thromb Haemost; 1981 Aug; 46(2):535-7. PubMed ID: 7302893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A.
    Ching S; Thoma A; Monkman S; Kelton JG
    Plast Reconstr Surg; 2003 Jul; 112(1):177-85. PubMed ID: 12832891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin compromises streptokinase-induced arterial patency in rabbits.
    Vlasin M; Rak J; Weitz JI; Peng L; Gumulec J; Johnston M; Klement P
    Thromb Res; 2005; 115(5):427-34. PubMed ID: 15733977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in vitro and in vivo in the rabbit.
    Nielsen VG; Arkebauer MR; Wasko KA; Malayaman SN; Vosseller K
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):104-7. PubMed ID: 22143252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE).
    JAMES DC; BROWSE NL
    Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065
    [No Abstract]   [Full Text] [Related]  

  • 30. Cavitational mechanisms in ultrasound-accelerated fibrinolysis.
    Prokop AF; Soltani A; Roy RA
    Ultrasound Med Biol; 2007 Jun; 33(6):924-33. PubMed ID: 17434661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of fibrinolysis with ultrasound energy.
    Tachibana K
    J Vasc Interv Radiol; 1992 May; 3(2):299-303. PubMed ID: 1627877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceleration of fibrinolysis by high-frequency ultrasound: the contribution of acoustic streaming and temperature rise.
    Sakharov DV; Hekkenberg RT; Rijken DC
    Thromb Res; 2000 Nov; 100(4):333-40. PubMed ID: 11113277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected].
    Lyden PD; Madden KP; Clark WM; Sasse KC; Zivin JA
    Stroke; 1990 Nov; 21(11):1589-93. PubMed ID: 2122552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prototype therapeutic ultrasound emitting catheter for accelerating thrombolysis.
    Tachibana K; Tachibana S
    J Ultrasound Med; 1997 Aug; 16(8):529-35. PubMed ID: 9315208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
    Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC
    Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodilution modulates the time of onset and rate of fibrinolysis in human and rabbit plasma.
    Nielsen VG
    J Heart Lung Transplant; 2006 Nov; 25(11):1344-52. PubMed ID: 17097499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.
    Wang YX; da Cunha V; Vincelette J; Zhao L; Nagashima M; Kawai K; Yuan S; Emayan K; Islam I; Hosoya J; Sullivan ME; Dole WP; Morser J; Buckman BO; Vergona R
    Thromb Haemost; 2007 Jan; 97(1):54-61. PubMed ID: 17200771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo.
    Biemond BJ; Friederich PW; Koschinsky ML; Levi M; Sangrar W; Xia J; Büller HR; ten Cate JW
    Circulation; 1997 Sep; 96(5):1612-5. PubMed ID: 9315555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human extrinsic plasminogen activator fibrinolytic properties and neutralization in vivo.
    Mattsson C; Nilsson S; Häggroth L
    Thromb Res; 1983 Apr; 30(1):91-100. PubMed ID: 6683005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolysis with tissue plasminogen activator (tPA) is temperature dependent.
    Yenari MA; Palmer JT; Bracci PM; Steinberg GK
    Thromb Res; 1995 Mar; 77(5):475-81. PubMed ID: 7778062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.